Evidence map›Paper›PMID 40745598›Full record

ReviewHarm reduction journal2025

How to eliminate hepatitis C between people who inject drugs in community services and prisons in Catalonia.

Elena Yela, Daniel G Abiétar, Rafael Clua-García

Abstract readReview
In one paragraph

Review in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elena YelaSant Esteve Sesrovires Prison Primary Care Team (Brians 1 Prison Centre), Catalan Health Institute, Barcelona, Spain. eyela@gencat.cat.
Daniel G AbiétarSouth Metropolitan Research Support Unit Foundation, University Institute for Research in Primary Health Care Jordi Gol i Gurina (IDIAPJGol), El Prat de Llobregat, , Spain.ORCID 0000-0002-5268-3574
Rafael Clua-GarcíaManresa Faculty of Health Sciences, University of Vic- Central University of Catalonia, Manresa, Spain.

Funding

GILEAD SCIENCES, Spain 6ª Convocatoria de Becas Gilead a proyectos de Microeliminación en Hepatitis C y Epidemiología en Hepatitis D 2023
6 · The paper itself

Abstract

backgroundThe Spanish National Health System, with devolved powers to autonomous communities such as Catalonia, faces significant challenges in controlling viral infections like hepatitis C (HCV) among vulnerable groups, particularly people who inject drugs (PWID), where prisons serve as crucial intervention sites. Catalonia's health authorities have implemented strategies to combat HCV, including direct-acting antiviral (DAA) treatments and harm reduction programmes within both community and penitentiary settings. However, substantial barriers persist in achieving full treatment uptake and clearance among PWID subpopulations. MAIN BODY: This review aims to discuss the Catalonia's current HCV programmes and explores intervention proposals needed to achieve WHO elimination targets. Catalonia has implemented a comprehensive HCV plan, particularly targeting PWID, that has proven effective through enhanced screening, universal treatment access, and harm reduction, though structural and social barriers remain due to fragmented health and social systems.

conclusionAdvancing towards HCV elimination requires strengthened inter-organisational coordination, integrated social and health services, simplified care pathways, enhanced screening, professional training, targeted research, measurable goals, culturally appropriate and participatory prevention strategies, and a comprehensive, people-centred approach. This is particularly important in prisons, where universal screening, adapted caring processes, harm reduction, and opioid substitution treatments (OST) are essential. Considering the social determinants of health perspective, it is essential that policies and programs are structured to reduce structural inequities and vulnerabilities, thereby promoting equity in both access to prevention, care, treatment, and health benefits across all population groups, particularly those most affected.

Indexed as

Community Health ServicesHepatitis CPrisonsSubstance Abuse, IntravenousAntiviral AgentsHarm ReductionHealth Services AccessibilityHumansPrisonersSpainAntiviral AgentsDirect-acting antiviralsHarm reductionHepatitis CPeople who inject drugs

Identifiers

PMID40745598
PMCPMC12312365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.